• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Voice Preservation

Making Our Voices Heard

Speech is a key part of a person’s identity. Voice matters to personal identity and expression, and connection with family and friends. The majority of people living with ALS/MND are eventually robbed of this fundamental part of their humanity.

This can be overcome using voice preservation technologies, but our research shows this is not equitably accessible. The Alliance seeks to provide universal access to technology to improve the quality of life of people living with ALS/MND. The ideal for every individual living with ALS/MND worldwide is to have the right to access voice preservation upon diagnosis.

The Voice Preservation Project

The Alliance, through a collaboration between Hospital Universitario Nacional de Colombia (HUN) and the Asociación Colombiana de ELA (ACELA), has launched a pilot project to deliver voice preservation technology to people living with ALS/MND in Colombia. This will serve as the basis on which future plans will be made on how best to scale to reach more people around the world.

If you would like to join us in expanding our reach to more people, please donate. We deeply appreciate your support.

Watch this video to find out more from the Alliance and its Information Technology Advisory Council (ITAC).

https://www.als-mnd.org/wp-content/uploads/2023/06/Voice-Preservation-ITAC-Intro.mp4

Watch this video to hear from Orlando Ruiz, founder of ACELA and a person living with ALS/MND, as he emphasizes the devastation of losing your voice. He goes on to explain the potential of voice banking technology to preserve dignity, autonomy and identity, and ensure no one loses their voice to ALS/MND.

 

Keep Up To Date

This project is in development and more details and information are coming soon! If you are interested in learning more, sign up to get periodic updates as the work progresses.

Subscribe

* indicates required
 
 

 

Disclaimer: Voice preservation is not designed, intended or made available for diagnosis, treatment or prevention of diseases or for use as a medical device. It is also not designed or intended to replace or be a substitute for professional medical advice, diagnosis, treatment or judgment.

Primary Sidebar

  • Zabun Nassar, England

    Zabun Nassar, England

  • Steve Lufkin, USA

    Steve Lufkin, USA
    IMG_3993

  • Teddy Hanono Annie, Mexico

    Teddy Hanono Annie, Mexico

  • Bjarne Hytjanstorp, Norway

    Bjarne Hytjanstorp, Norway

  • Vincent Bourque, Canada

    Vincent Bourque, Canada
    vincent_bourque

  • Claudette Sturk, Canada

    Claudette Sturk, Canada
    Picture2

  • Daniel Hare, USA

    Daniel Hare, USA

  • Lin Yong Yi, Taiwan

    Lin Yong Yi, Taiwan

  • Bayley, Australia

    Bayley, Australia

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Paul Launer, USA

    Paul Launer, USA

  • Rolf Mauch, Switzerland

    Rolf Mauch, Switzerland

  • Mikey Stone, ALS

    Mikey Stone, ALS

  • Greg Heydet, USA

    Greg Heydet, USA

  • Margarita Pizarro, Argentina

    Margarita Pizarro, Argentina

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • Angelique van der Lit-van Veldhuizen, Netherlands

    Angelique van der Lit-van Veldhuizen, Netherlands

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Jack Buzby, USA

    Jack Buzby, USA

  • Anderson Custodio Pinto, Brazil

    Anderson Custodio Pinto, Brazil

  • Jason Goodman, USA

    Jason Goodman, USA

  • Feng Gin Sun, China

    Feng Gin Sun, China

  • Shaleen Latchman, Canada

    Shaleen Latchman, Canada

  • David Hall, USA

    David Hall, USA

  • Christian Bär, Germany

    Christian Bär, Germany

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Liz Ogg, Scotland

    Liz Ogg, Scotland

  • Lee Millard, England

    Lee Millard, England

  • Glen Victor Peters, Australia

    Glen Victor Peters, Australia

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Bruno Leanza Mantegna, Italy

    Bruno Leanza Mantegna, Italy

  • Art Eggert, USA

    Art Eggert, USA

  • Hans Dieter Olszewski, Germany

    Hans Dieter Olszewski, Germany

  • Liam Dwyer, England

    Liam Dwyer, England

  • Ada Garrido Benavidez, Mexico

    Ada Garrido Benavidez, Mexico

  • Wendy Hendrickson, USA

    Wendy Hendrickson, USA

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Kirsten Harley, Australia

    Kirsten Harley, Australia

  • Ching-Liang Chu, Taiwan

    Ching-Liang Chu, Taiwan

  • Ian Gale, Australia

    Ian Gale, Australia

  • Imelda Arenas, Colombia

    Imelda Arenas, Colombia

  • Diana Fernandez, Argentina

    Diana Fernandez, Argentina

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Valdomiro Xavier Honório, Brazil

    Valdomiro Xavier Honório, Brazil

  • Juvenal Bayona Romero, Colombia

    Juvenal Bayona Romero, Colombia

  • Horacio Fritzer, Argentina

    Horacio Fritzer, Argentina

  • Mauricio Dorin, Argentina

    Mauricio Dorin, Argentina

  • Bob Simonds, USA

    Bob Simonds, USA

  • Stephanie Christiansen Hall, Canada

    Stephanie Christiansen Hall, Canada

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login